Evidence map›Paper›PMID 42177354›Full record

ArticleAntonie van Leeuwenhoek2026

Scorpion gut microbiomes as a source of bioactive and rare actinobacteria with nonribosomal peptide potential.

N Hashemian, J Hamedi, S Haghighat

Abstract read
PubMed Publisher
In one paragraph

Article in Antonie van Leeuwenhoek, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

N HashemianDepartment of Microbiology, TeMS.C., Islamic Azad University, Tehran, Iran.
J HamediDepartment of Applied Biology (Department of Microbial Biotechnology), School of Biology and Center of Excellence in Phylogeny of Living Organisms, College of Science, University of Tehran, Tehran, Iran. jhamedi@ut.ac.ir.ORCID http://orcid.org/0000-0002-0491-2205
S HaghighatDepartment of Microbiology, TeMS.C., Islamic Azad University, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Actinobacteria are well-known for their ability to produce bioactive secondary metabolites, including nonribosomal peptides (NRPs); however, many host-associated reservoirs remain underexplored. In this study, cultivable actinobacteria were isolated from scorpion gut, including both the intestinal tissue and its luminal contents, and evaluated their antimicrobial activity and presence of NRPs genes. Fifty scorpions (Odontobuthus doriae and Mesobuthus eupeus) were collected from Qom Province, Iran. Dissected gut homogenates were plated on selective media, yielding 120 pure isolates. Taxonomic identification was performed by 16S rRNA gene sequencing, antimicrobial activity was assessed using agar diffusion assays against a broad panel of bacteria and fungi, and isolates were screened for NRPS gene biosynthetic markers by PCR (using A3F/A7R primers). The collection was dominated by Streptomyces, with additional recovery of rarer genera such as Amycolatopsis and Nonomuraea. Overall, 57% of the isolates inhibited at least one test microorganisms, and some strains exhibited specific bioactivity, making them candidates for further investigation. NRPS amplicons (~ 700 bp) were detected in 33.3% of the isolates and were enriched among the 42.6% of bioactive isolates, suggesting a partial association between antimicrobial phenotypes and putative NRP biosynthetic capacity. Five isolates showed < 98.5% 16S rRNA similarity to described species, indicating potential taxonomic novelty. Collectively, these findings support scorpion guts as promising, niche-derived sources of diverse actinobacteria with antimicrobial activity and biosynthetic potential for natural product discovery.

Indexed as

ActinobacteriaPeptide Biosynthesis, Nucleic Acid-IndependentScorpionsAnimalsAnti-Infective AgentsDNA, BacterialMicrobiotaPhylogenyRNA, Ribosomal, 16SAnti-Infective AgentsDNA, BacterialRNA, Ribosomal, 16SActinobacteriaDesertMicrobiomeNon-ribosomal peptides (NRPs)Scorpion

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.